f-18 pmpbb3
Small moleculeexperimentalImaging agent
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Sep 21, 2018 (NCT04309253)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04318626 | Phase 2 | May 1, 2020 | Chang Gung University |
| NCT04305210 | Phase 2 | Dec 1, 2019 | Chang Gung University |
| NCT04169126 | Phase 2 | Apr 1, 2019 | Chang Gung University |
| NCT04309253 | Phase 2 | Sep 21, 2018 | Chang Gung University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chang Gung University | Academic/Hospital | 4 | 4 | 1 | 2018 |
1 organizations
Page 1 / 1